Viewing Study NCT01833767


Ignite Creation Date: 2025-12-25 @ 12:27 AM
Ignite Modification Date: 2026-01-04 @ 4:54 AM
Study NCT ID: NCT01833767
Status: WITHDRAWN
Last Update Posted: 2017-08-24
First Post: 2013-04-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Low-dose Cyclophosphamide and Outpatient IV Interleukin-2 in Metastatic Melanoma
Sponsor: Western Regional Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 12-12
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators